ESR1 and serous adenocarcinoma: In our current study, we found that the majority of serous carcinomas of borderline epithelial ovarian cancer were ER and PR positive (93%), whilst 28% or 33% of women with mucinous carcinoma of borderline epithelial ovarian cancer were ER or PR positive.